NCT06982131: A Study Investigating the Safety of RO7795081 and the Effect of RO7795081 on How the Body Processes Pitavastatin and Rosuvastatin in Otherwise Healthy Overweight or Obese Adult Participants

Sponsor: Hoffmann-La Roche. Phase: PHASE1. Conditions: Overweight, Obesity